ArticleFrontiers in epidemiology2026
Identifying and resolving ethical challenges related to the enrollment of black individuals with chronic kidney disease in U.S. health registries and clinical research: a qualitative study.
Article in Frontiers in epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Chronic kidney disease (CKD) disproportionately impacts Black individuals. This disparity, coupled with historical and ongoing injustices in medical research, raises significant ethical concerns that may hinder participation in health registries and clinical research, which are critical for advancing patient-centered kidney care. This study sought to identify key ethical challenges from the perspective of Black individuals with CKD to enhance their meaningful and equitable engagement. Methods: We employed a qualitative approach guided by a pragmatist bioethical framework. We conducted three virtual town hall meetings with a sample of 24 self-identified Black adults with CKD and their caregivers, recruited from the Baltimore Metropolitan Area. Data were analyzed using thematic analysis. To ensure rigor, we employed intercoder reliability checks and member-checking with participants and a Community Advisory Board. Results: Six primary ethical areas emerged: (1) lack of transparent communication, (2) distrust in the research enterprise, (3) experiences of stigmatization and discrimination, (4) cultural insensitivity, (5) lack of respect and civility, and (6) potential harm from poor-quality staff. Participants proposed and prioritized actionable solutions, including implementing mandatory transparent communication policies, enhancing community-engaged outreach, enforcing anti-discrimination legislation, providing cultural competency training for staff, and establishing rigorous quality control measures with patient input. Conclusion: Addressing these multi-faceted ethical challenges through targeted, trust-building strategies is essential to enhance the participation of Black individuals in health registries and clinical studies. This, in turn, can lead to more equitable representation in kidney research and more generalizable findings to reduce CKD disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.